Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study
DAA treatment in HCV-related cirrhosis significantly reduces variceal rebleeding, ascites development, and hepatic dysfunction progression. The 5-year follow-up data demonstrate sustained improvements in liver function and hematologic parameters, underscoring the long-term benefits of DAA therapy.
Authors
- Atteyat A. Semeya
- Rania Hafez (ORCID: https://orcid.org/0000-0003-0596-0249)
- Rasha Elgamal (ORCID: https://orcid.org/0009-0000-5327-7052)
- Amira A. A. Othman (ORCID: https://orcid.org/0000-0002-8191-0035)
Institutions
- Suez University (EG)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.4254/wjh.v17.i11.110638
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00